Lilly’s ambitious diabetes drug Mounjaro fails to impress in the fourth quarter By: MarketWatch February 02, 2023 at 13:49 PM EST The new Type 2 diabetes treatment may be in high demand, but sales came in far below Wall Street’s expectations. Read More >> Related Stocks: Eli Lilly
